Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Pehoushek
J
J
National Naval Medical Center, Bethesda, MD 20889-5600, USA.
Smith
K J
KJ
D000634:Aminoquinolines / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002278:Carcinoma in Situ / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008875:Middle Aged
D000634:Aminoquinolines; D000077271:Imiquimod; D005472:Fluorouracil